Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
Actinium Pharmaceuticals, Inc. (ATNM)
Standardized SEC financial data for Actinium Pharmaceuticals, Inc. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001388320 · NYSE · Pharmaceutical Preparations.
Revenue growth (YoY)
11.1%
Return on equity
-432.6%
Free cash flow
-$24.7M
Debt / equity
0.12×
Current ratio
6.20×
EPS (diluted)
$-1.09
Ratios for fiscal year 2025, standardized from SEC filings.